Related Experiment Video
Updated: Apr 10, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
Establishment and mutation analysis of a novel malignant peritoneal mesothelioma cell line, TU-MM-1, using whole
Nao Oumi1, Hiroaki Itamochi2, Hiroaki Komatsu1
1Department of Obstetrics and Gynecology, Tottori University School of Medicine, 36-1 Nishicho, Yonago, Tottori, 683-8504, Japan.
Abstract:
A new cell line of human malignant peritoneal mesothelioma (MPM), TU-MM-1, was established and characterized. The cells showed polygonal morphology, grew in monolayers without contact inhibition and were arranged like a jigsaw puzzle. The chromosome numbers ranged from 41 to 44. A low rate of proliferation was observed and the doubling time was 67.9 h. Genomic DNA sequencing revealed that TU-MM-1 cells harbored missense mutations in APC, LATS2, BRCA1/2, and TP53, and mutation of a splice donor site in BAP1 and loss of CDKN2A gene. We observed the absence of BAP1 and p16(INK4a) proteins, underexpression of LATS2 protein, and overexpression of p53 protein in TU-MM-1 cells in western blot analysis. Heterotransplantation to nude mice produced tumors that had the characteristics of the original tumor. This cell line may be useful for studying biological properties and contribute to novel treatment strategies.
Insights
A new human malignant peritoneal mesothelioma (MPM) cell line, TU-MM-1, was developed. This characterized cell line, with specific genetic mutations, shows promise for studying MPM and developing new treatments.
Area of Science:
- Oncology
- Cell Biology
- Genetics
Background:
- Malignant peritoneal mesothelioma (MPM) is a rare and aggressive cancer.
- Establishing well-characterized cell lines is crucial for understanding MPM biology and developing targeted therapies.
Purpose of the Study:
- To establish and characterize a new human MPM cell line, TU-MM-1.
- To evaluate its potential utility in preclinical research and therapeutic strategy development.
Main Methods:
- Cell culture and morphological analysis.
- Karyotyping and proliferation rate assessment.
- Genomic DNA sequencing and Western blot analysis.
- Heterotransplantation into nude mice.
Main Results:
- TU-MM-1 cells exhibited polygonal morphology, monolayer growth without contact inhibition, and aneuploidy (41-44 chromosomes).
- Genetic analysis revealed mutations in APC, LATS2, BRCA1/2, TP53, BAP1, and CDKN2A, with corresponding protein expression changes (loss of BAP1/p16INK4a, altered LATS2/p53).
- Heterotransplantation successfully generated tumors with MPM characteristics.
Conclusions:
- The TU-MM-1 cell line is a valuable new model for MPM research.
- Its genetic and molecular profile provides insights into MPM pathogenesis.
- This cell line can facilitate the study of MPM biological properties and the development of novel treatment strategies.
More Related Videos
09:14Author Spotlight: A Pipeline to Analyze Lineage-Specific Mutant Embryos at Single-Cell Resolution
Published on: June 14, 2024
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023